Aurinia Pharmaceuticals Inc. (AUPH)
NASDAQ: AUPH · Real-Time Price · USD
16.73
+0.12 (0.72%)
At close: Oct 15, 2026, 4:00 PM EDT
16.80
+0.07 (0.42%)
After-hours: Oct 15, 2026, 7:30 PM EDT
Aurinia Pharmaceuticals Employees
Aurinia Pharmaceuticals had 128 employees as of December 31, 2025. The number of employees decreased by 2 or -1.54% compared to the previous year. That makes Aurinia Pharmaceuticals the 29,864th largest employer in the world and 3,827th in the United States.
Employees
128
Change (1Y)
-2
Growth (1Y)
-1.54%
Revenue / Employee
$2,433,648
Profits / Employee
$2,454,016
Market Cap
2.23B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 128 | -2 | -1.54% |
| Dec 31, 2024 | 130 | -170 | -56.67% |
| Dec 31, 2023 | 300 | 0 | - |
| Dec 31, 2022 | 300 | 0 | - |
| Dec 31, 2021 | 300 | 6 | 2.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Fortrea Holdings | 14,000 |
| Novavax | 749 |
| Recursion Pharmaceuticals | 600 |
| Vericel | 398 |
| Harmony Biosciences Holdings | 293 |
| Viridian Therapeutics | 252 |
| Celldex Therapeutics | 198 |
| Disc Medicine | 165 |
AUPH News
- 6 weeks ago - LB Pharmaceuticals appoints Joseph Miller as CFO - TheFly
- 1 month ago - Aurinia settles patent litigation with Teva - TheFly
- 1 month ago - Aurinia Settles Patent Litigation with Teva - Business Wire
- 2 months ago - Aurinia Pharmaceuticals price target raised to $16 from $15 at RBC Capital - TheFly
- 2 months ago - Aurinia Pharmaceuticals sees FY26 revenue $315M-$325M, consensus $325.82M - TheFly
- 2 months ago - Aurinia Pharmaceuticals reports Q2 EPS 28c, consensus 24c - TheFly
- 2 months ago - Aurinia Pharmaceuticals Reports Financial Results for the Three and Six Months Ended June 30, 2026 and Provides Update on Recent Business Progress - Business Wire
- 2 months ago - Aurinia Pharmaceuticals Earnings release: Q2 2026 - Filings